Mouse Anti-FOXN2 Recombinant Antibody (CBXF-1786) (CBMAB-F3321-CQ)

Jeong, S., Kim, S. A., & Ahn, S. G. (2022). HOXC6-Mediated miR-188-5p expression induces cell migration through the inhibition of the tumor suppressor FOXN2. International Journal of Molecular Sciences, 23(1), 9.

Liu, X. H., Liu, L. P., Xu, X. M., Hua, M., Kang, Q., Li, A., & Huang, L. (2021). FOXN2 suppresses the proliferation and invasion of human hepatocellular carcinoma cells. Eur. Rev. Med. Pharmacol. Sci, 25, 731-737.

Santibanez, B., Oliveira, S., Duggan, K., Lu, K., & Johnson, K. (2019). Abstract C49: Knockdown of FOXN2 enhances adhesion and reduces migration in pancreatic cancer cells. Cancer Research, 79(24_Supplement), C49-C49.

Dai, S. G., Guo, L. L., Xia, X., & Pan, Y. (2019). Long non-coding RNA WT1-AS inhibits cell aggressiveness via miR-203a-5p/FOXN2 axis and is associated with prognosis in cervical cancer. Eur Rev Med Pharmacol Sci, 23(2), 486-495.

Ye, H., & Duan, M. (2019). FOXN2 is downregulated in breast cancer and regulates migration, invasion, and epithelial–mesenchymal transition through regulation of SLUG. Cancer Management and Research, 11, 525.

Ma, J., Lu, Y., Zhang, S., Li, Y., Huang, J., Yin, Z., ... & Xu, S. (2018). β-Trcp ubiquitin ligase and RSK2 kinase-mediated degradation of FOXN2 promotes tumorigenesis and radioresistance in lung cancer. Cell Death & Differentiation, 25(8), 1473-1485.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols